Journal
Cheapest FDA-Approved vs Compounded GLP-1 Options
Separate starter, ongoing, annual and dose-tier prices
The cheapest FDA-approved GLP-1 for weight loss is now $149 a month — orforglipron through LillyDirect or oral Wegovy tablets through NovoCare. Most compounded programmes run $169 to $399. A compounded programme priced above $299 costs more than brand Zepbound direct from the manufacturer, and several of them are.
The comparison everyone stopped updating
For two years the arithmetic was simple. Brand GLP-1s listed above $1,000 a month, compounded alternatives ran $200 to $400, and the gap was the entire business model of GLP-1 telehealth.
Brand prices then fell sharply, and most comparison pages never updated. Zepbound is now $299 to $449 direct from LillyDirect. Wegovy is $349 through NovoCare, with oral Wegovy tablets at $149. Orforglipron, Lilly's approved oral GLP-1, starts at $149. With commercial insurance that covers them, either brand can land near $25.
Against a compounded market that mostly prices between $169 and $399, that is no longer a large gap. In parts of the market it has inverted.
Where the inversion actually bites
Sixteen of the compounded offerings in our pricing dataset cost more than $299 a month. Every one of those is more expensive than brand Zepbound bought directly from its manufacturer — an FDA-approved product, reviewed for safety, effectiveness and manufacturing quality, supplied through the company that makes it.
Some of the differences are extreme. Several telehealth platforms resell brand-name drugs close to retail: one lists brand Wegovy at $1,794 a month all-in when NovoCare sells the identical medicine direct for $349. That is disclosed pricing rather than fraud, but it is a fourfold to twelvefold difference for the same product from the same manufacturer.
The catch, stated fairly
Two things complicate the picture, and a page that omitted them would be doing what we are criticising.
Titration. The $149 orforglipron price is the 0.8 mg starter dose. It rises to $199, then $299, then $349 as the dose increases — with its own 45-day refill rule that returns it to $299 if you refill in time. Zepbound behaves similarly: $299 at 2.5 mg, $399 at 5 mg, $449 at 7.5 to 15 mg, and the rate holds only with a refill inside 45 days. Some compounded programmes charge one flat price at every dose, which is worth real money to a patient at a maintenance dose.
The lowest compounded prices are genuinely lower. Microdose programmes reach $110 to $147 a month. But a microdose sits below every dose used in the trials, which is a different product with a smaller expected effect, not a discount on the same treatment.
How to work out which applies to you
Three questions settle it.
- What dose will I actually be on? If you expect to maintain at a low dose, the approved oral at $149 is hard to beat. If you expect a high maintenance dose, a flat-rate compounded programme may win on arithmetic.
- Does my insurance cover a brand product? Check before anything else. Coverage changes the answer completely and most people never ask.
- Am I comparing like with like? A compounded microdose against an approved full dose is not a price comparison, it is two different treatments with two different expected effects.
What this does not say
It does not say compounded medicines are bad, or that everyone should switch. It says the price argument that justified the compounded market has weakened substantially, and that anyone paying more than $299 a month for a compounded product should know they could buy the FDA-approved version for less.
Show this figure as a table
| Item | Mean reduction | Evidence |
|---|---|---|
| Tirzepatide 15 mg (SURMOUNT-1) | 21% | Verified |
| Oral semaglutide 25 mg, adherent (OASIS 4) | 17% | Verified |
| Injectable semaglutide 2.4 mg (SURMOUNT-5) | 14% | Verified |
| Oral semaglutide 25 mg, treatment-policy (OASIS 4) | 14% | Verified |
| Orforglipron 17.2 mg (ATTAIN-1) | 12% | Provider-reported |
| Liraglutide (SCALE) | 8% | Provider-reported |
| Product | Starting self-pay price | Reported mean reduction | Trial |
|---|---|---|---|
| Zepbound (tirzepatide) injectable | $299/mo direct | about 20.9% at 15 mg | SURMOUNT-1, 72 weeks |
| Wegovy pill (oral semaglutide 25 mg) | $149/mo starting dose | 13.6–16.6% depending on estimand | OASIS 4, 64 weeks |
| Wegovy injectable (semaglutide 2.4 mg) | $349/mo maintenance | about 13.7% | SURMOUNT-5, 72 weeks |
| Foundayo (orforglipron) | $149/mo starting dose | about 11–12.4% at 17.2 mg | ATTAIN-1, 72 weeks |
Show this figure as a table
| Item | Orforglipron | Oral Wegovy |
|---|---|---|
| FDA-approved oral, starter | $149 | $149 |
| FDA-approved injectable, direct | $299 | $349 |
| Cheapest compounded standard | $169 | $133 |
| Typical compounded standard | $280 | $199 |
Show this figure as a table
| Item | Value | Evidence |
|---|---|---|
| Orforglipron 0.8 mg | $149 | Verified |
| Orforglipron 2.5 mg | $199 | Verified |
| Orforglipron 5.5–9 mg | $299 | Verified |
| Orforglipron 14.5–17.2 mg | $349 | Verified |
| Program type | What it covers | Comparable with |
|---|---|---|
| Starter program | Introductory period, often lower doses | Other starter programs only |
| Ongoing program | Standard continuing supply | Other ongoing programs only |
| Maintenance program | Post-titration supply, often a fixed dose | Other maintenance programs only |
| Prepaid term | Several months paid upfront | Monthly plans only after conversion |
| Month-to-month | Cancellable each cycle | Other month-to-month plans only |
| Microdose program | Sub-therapeutic dosing outside trial evidence | Other microdose programs only |
Questions readers actually ask
What is the cheapest FDA-approved GLP-1 for weight loss?
At the starting dose, $149 a month — orforglipron through LillyDirect, or oral Wegovy tablets through NovoCare. Both rise with dose.
Is compounded always cheaper than brand?
No. Not any more. Sixteen compounded offerings in our dataset cost more than brand Zepbound bought direct from Lilly at $299.
Why do some telehealth platforms charge over $1,000 for brand drugs?
They resell at close to retail rather than routing you to the manufacturer's own self-pay programme. Always price a brand drug at LillyDirect or NovoCare before buying it through a platform.
Related on this site
- The journalJournal
- Retatrutide Phase 3 Results: What Changed in July 2026Journal
- FDA Compounded GLP-1 Rules in 2026Journal
- How to Spot Fraudulent Compounded GLP-1 LabelsJournal
- The 100-point rubricCore & Trust
- Cost calculatorTools
- The underlying price recordsData
- Zepbound vs Compounded TirzepatideComparisons
- Brand-Name vs Compounded GLP-1Comparisons
- Zepbound vs Compounded TirzepatidePillar / Money
GLP-1 Tirzepatide Review. “Cheapest FDA-Approved vs Compounded GLP-1 Options.” S.J Partners LLC, 2026-07-24. https://glp1tirzepatidereview.com/journal/cheapest-fda-approved-vs-compounded-glp1/
When quoting a figure, include the capture date shown beside it rather than the date you read this page. A price without its capture date is not a usable citation.